Seeking Alpha

VNDA
  Vanda Pharmaceuticals Inc. - NASDAQ

8/21/2014, 12:40 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
VNDA vs. ETF Alternatives
Company Description
Vanda Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders such as HETLIOZ, Fanapt and VLY-686.
Sector: Healthcare
Industry: Biotechnology
Country: United States